PATRICIA KRAYCINOVICH: Open Payments
NPI 1497269625 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 65 payments from 16 companies in 2025. Trend: 2023 $849 · 2024 $1,019 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $177 |
| ABBVIE INC. | 11 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $164 |
| PFIZER INC. | 13 | $146 |
| Janssen Biotech, Inc. | 7 | $113 |
| Aimmune Therapeutics, Inc. | 3 | $58 |
| QOL Medical, LLC | 2 | $47 |
| Ardelyx, Inc. | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| VIVUS LLC | 2 | $32 |
Products named: REZDIFFRA, VELSIPITY, ENTYVIO, TREMFYA, RINVOQ, ZENPEP, SKYRIZI, Sucraid.
Industry payments across NJ — which companies pay providers there.
